BHBehnam Hajipour-Verdom

Behnam Hajipour-Verdom

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Behnam Hajipour-Verdom has a total of 51 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Alpha-synuclein pathobiology and therapeutic targeting in Parkinson’s disease

    by Sina Reyhani, Mozhgan Alipour, Behnam Hajipour-Verdom, Parviz Abdolmaleki

    Background and purpose: Alpha-synuclein (α-Syn) is a presynaptic protein involved in synaptic vesicle trafficking, neurotransmitter release, and membrane remodelling. Its misfolding and pathological aggregation are central to Parkinson’s disease (PD) and related synucleinopathies. This review examines how structural changes, post-translational modifications (PTMs), and interactions with proteins, lipids, metal ions, and cellular organelles regulate α-Syn function and contribute to neurodegeneration and evaluates the implications of these mechanisms for biomarker development and therapeutic targeting. Experimental approach: This review synthesizes and critically discusses existing literature on α-Syn structure and physiological functions, molecular interactions, aggregation pathways, cellular toxicity, and the roles of PTMs in protein homeostasis and disease progression. It also evaluates emerging diagnostic approaches, including seed amplification assays and analyses of cerebrospinal fluid, blood, and extracellular vesicles, alongside therapeutic strategies targeting α-Syn aggregation, clearance, and expression. Key results: The reviewed evidence indicates that α-Syn pathobiology arises from the interplay of conformational plasticity, molecular interactions, PTMs, and impaired cellular proteostasis. These processes contribute to mitochondrial dysfunction, lysosomal impairment, neuroinflammation, and the propagation of pathological α-Syn assemblies. Seed amplification assays and other molecular biomarker approaches show promise for improving detection and characterization of synucleino­pathies, while immunotherapies, aggregation inhibitors, gene-based interventions, and strategies that enhance protein clearance represent potential disease-modifying approaches. However, diagnostic standardization and the demonstration of unequivocal clinical efficacy remain important challenges. Conclusion: Integrating α-Syn molecular biology with advances in biomarker development and therapeutic research provides a framework for understanding disease heterogeneity and identifying mechanism-based interventions. This review highlights the need to move beyond reducing α-Syn burden toward selectively preventing pathogenic conformations while preserving its physiological functions. Further validation in clinical studies is essential to establish the diagnostic utility and therapeutic effectiveness of these approaches.

  • Open Access

    Magnetoreceptive CRY/MagR complexes: linking circadian redox signalling to protein aggregation in Alzheimer’s and Parkinson’s disease

    by Mozhgan Alipour, Behnam Hajipour-Verdom, Faria Ashrafi, Sara Rahmati Roodsari, Shabnam Nohesara, Alireza Zali, Farzad Ashrafi

    Background and purpose: Neurodegenerative disorders such as Alzheimer’s disease (AD) and Parkinson’s disease (PD) pose an escalating challenge to neuroscience, as disease-modifying therapies remain elusive despite substantial advances in molecular and cellular understanding. These disorders share convergent pathological features, including protein misfolding and aggregation, mitochondrial dysfunction, oxidative stress, impaired proteostasis, and disruption of circadian regulation. Identifying integrative frameworks that connect these processes is therefore essential for advancing conceptual models of neurodegeneration. This review examines magneto-proteins, with a particular focus on CRY/MagR-based magnetoreceptor complexes, as emerging biological systems that may intersect with key molecular pathways implicated in AD and PD. Experimental approach: We synthesized literature from neuroscience, biophysics, and circadian biology to evaluate the potential relevance of magnetoreceptor mechanisms to AD and PD pathology. We first summarized the core neuropathological mechanisms underlying both diseases, including amyloid-β and tau pathology in AD and α-synuclein aggregation and dopaminergic vulnerability in PD. We then outlined the biophysical foundations of magneto-protein function, emphasizing cryptochrome-mediated radical pair mechanisms, iron-sulfur cluster-dependent magnetic sensitivity, and their established roles in redox signaling and circadian biology. Key results: Accumulating experimental evidence from cellular and animal models suggests that CRY/MagR-associated pathways can modulate oxidative stress, mitochondrial bioenergetics, protein aggregation dynamics, autophagic processes, and circadian control of neuronal metabolism. These processes closely overlap with molecular determinants of neuronal vulnerability in AD and PD. However, direct validation in mammalian and human systems remains limited and controversial, representing a critical knowledge gap. Conclusion: The mechanistic convergence between magnetoreceptor biology and neurodegenerative pathology warrants critical evaluation but remains largely speculative in humans. By integrating findings across disciplines, this review positions CRY/MagR-based magneto-proteins as a conceptual platform for exploring how magnetic field-responsive molecular systems may inform our understanding of neurodegenerative disease mechanisms, while emphasizing the need for rigorous mammalian validation.


  • Open Access

    Liposome-mediated gene delivery: A comprehensive review of biophysical parameters, lipid composition and targeting strategies

    by Erfan Jafari Sale, Mohammad Satari, Behnam Hajipour-Verdom

    Background and purpose: Gene therapy has emerged as a transformative strategy for treating genetic and acquired disorders, but its clinical success relies heavily on the development of safe, efficient, and target-specific delivery vectors. Experimental approach: The paper systematically analysed published evidence on liposome composition, physicochemical behaviour, targeting strategies, and their applications in delivering diverse nucleic acids, with emphasis on the structure-function relationships of lipid components and the impact of biophysical parameters on transfection efficiency. Key results: Current findings demonstrate that the molecular architecture of cationic, neutral, and anionic lipids, particularly variations in head groups, linkers, and hydrophobic tails, strongly dictates liposome stability, cellular uptake, and cargo release. Biophysical attributes such as vesicle size, zeta potential, membrane fluidity, fusion capacity, and PEGylation were identified as major determinants of in vivo fate. Active targeting through ligands, including antibodies, peptides, folate, and aptamers, enhances cell-specific delivery, while combinatorial approaches with physical enhancement techniques such as sonoporation and electroporation further improve nucleic acid transport. Conclusion: By integrating structural, functional, and application-based insights, this review highlights key design principles for optimizing next-generation liposomal vectors, although challenges remain in achieving consistent in vivo performance and clinical translation. The work advances the field by offering a unified framework to guide rational engineering of liposomal platforms for gene therapy.


  • Dual-modal fluorometric and colorimetric label-free pyrrole-functionalized semiconducting polymer dots for highly efficient 2,4,6-trinitrotoluene detection in environmental samples and cellular imaging

    by Mousa Zare Moghadam, Mojtaba Shamsipur, Mozhgan Alipour, Vahid Yousefi, Behnam Hajipour-Verdom, Mohammad Moodi, Saman Hosseinkhani, Morteza Hosseni, Mehrbod Mehrafza, Fatemeh Molaabasi

  • Open Access

    Nano-biomaterials in cancer therapy: Advances in targeting and overcoming cancer stem cell resistance

    by Marzieh Dehghani, Behnam Hajipour-Verdom=, Fatemeh Rahimzadeh, Parviz Abdolmaleki

    Background and purpose: Cancer remains a leading cause of death globally, with long-term treatment success hindered by metastasis, recurrence, and therapy resistance. A central driver of these limitations is cancer stem cells (CSCs) - a rare subpopulation of tumour cells endowed with self-renewal and differentiation potential. CSCs contribute critically to tumour progression, metastatic spread, and resistance to conventional therapies, yet no clinically validated strategies currently exist to accurately detect or selectively eliminate them. Review approach: The paper systematically examined the literature on CSC origin, phenotypic characterization, isolation techniques, and mechanisms underlying resistance, including dormancy, enhanced DNA repair, apoptosis evasion, and microenvironmental protection. Particular attention was given to recent advances in nanomaterial-based strategies - metallic, carbon, and organic nanocarriers, designed to improve CSC-specific drug delivery, reactive oxygen species generation, pathway inhibition, and modulation of the CSC niche. Key results: Current CSC markers and in vivo models remain ambiguous and poorly standardized, limiting translational progress. Nanotechnology provides promising solutions by enabling targeted delivery and multi-functional therapy integration, yet most systems are still at the preclinical stage, constrained by issues of biocompatibility, targeting precision, and manufacturing scalability. Conclusion: Multifunctional nanoplatforms hold substantial potential to overcome CSC-driven resistance, improve therapeutic selectivity, and reduce recurrence. However, rigorous optimization and clinical validation are essential before these technologies can be integrated into routine oncology. This review advances understanding by outlining the intersection of CSC biology and nanomedicine, emphasizing translational pathways for CSC-targeted cancer therapy. .


  • Interaction of α-synuclein with DJ-1 in homodimer and L166P mutant monomer forms in Parkinson’s disease: a molecular dynamics study

    by Mozhgan Alipour, Behnam Hajipour-Verdom, Alireza Zali, Farzad Ashrafi, Parviz Abdolmaleki, Saeed Oraee-Yazdani, Meisam Akhlaghdoust, Nastaran Karimi

    Parkinson's disease (PD) is a progressive neurodegenerative disorder that is characterized by the formation of Lewy bodies, which are primarily composed of misfolded α-Synuclein (α-Syn). DJ-1 is a crucial protein involved in the correct folding of α-Syn, and mutations impairing its function are associated with the onset of PD. One such mutation, the L166P substitution in DJ-1, which has been linked to early-onset PD and results in the loss of DJ-1's homodimer structure. Recent studies have shown the presence of DJ-1 in Lewy bodies, but its interaction with α-Syn is unknown. Therefore, in this study, we investigated the interaction between α-Syn and DJ-1 in both its wild-type (wDJ-1: homodimer) and L166P mutant (mDJ-1: monomer) forms using molecular dynamics simulation. Our results indicated that α-Syn binds more tightly to mDJ-1 than to wDJ-1. Gibbs free energy landscape analysis showed that the bonded α-Syn to mDJ-1 complex represents a stable conformation, whereas only a partial connection of α-Syn to wDJ-1 was observed. Generally, it appears that the monomer form of DJ-1 resulting from the L166P mutation can form a stable complex with α-Syn, potentially intensifying the formation of Lewy bodies. Thus, the identification of aggregated α-Syn with DJ-1 may serve as a potential biomarker for PD.


  • Prediction of size-selective permitted daily exposures for mineral oil mist based on an in vitro study in different scenarios

    by Zahra Moradpour, Rezvan Zendehdel, Behnam Hajipour-Verdom, Parviz Abdolmaleki, Ali Khavanin, Masoomeh Vahabi Shekarloo

    The incidence of DNA damage from exposure to specific types of metalworking fluids has been reported. In this research, size-selective permissible limits to prevent genotoxic damage in A549 cell lines exposed to two types of mineral oil were estimated for the first time using a benchmark dose approach and extrapolated to workers. The comet assay was performed based on Olive and Banath protocol to determine DNA damage. Then, the Benchmark Dose, the 95% lower bound confidence limit BMD, and the 95% upper-bound confidence limit BMD were determined using continuous response data. Finally, the four Benchmark Dose levels reported in the A549 cell line were extrapolated to the human population in occupational settings in two phases. This study showed when determining the permissible limits, the type used or unused, the type of injury, the organ affected in the body and the size of the particles should also be considered.

  • Lung cell toxicity of co-exposure to airborne particulate matter and extremely low-frequency magnetic field

    by Zahra Panjali, Parviz Abdolmaleki, Behnam Hajipour-Verdom, Omar Hahad, Rezvan Zendehdel

    Although the toxic effects of urban airborne particulate matter (PM) have been known on lung cells, there is less attention to co-exposure to PM and extremely low frequency magnetic (ELF-MF) in occ...


  • Open Access

    Shape-Controlled Synthesis of Luminescent Hemoglobin Capped Hollow Porous Platinum Nanoclusters and their Application to Catalytic Oxygen Reduction and Cancer Imaging

    by Fatemeh Molaabasi, Morteza Sarparast, Mojtaba Shamsipur, Leila Irannejad, Ali Akbar Moosavi-Movahedi, Abouzar Ravandi, Behnam Hajipour Verdom, Reza Ghazfar

    Engineering hollow and porous platinum nanostructures using biomolecular templates is currently a significant focus for the enhancement of their facet-dependent optical, electronic, and electrocatalytic properties. However, remains a formidable challenge due to lack of appropriate biomolecules to have a structure-function relationship with nanocrystal facet development. Herein, human hemoglobin found to have facet-binding abilities that can control the morphology and optical properties of the platinum nanoclusters (Pt NCs) by regulation of the growth kinetics in alkaline media. Observations revealed the growth of unusual polyhedra by shape-directed nanocluster attachment along a certain orientation accompanied by Ostwald ripening and, in turn, yield well-dispersed hollow single-crystal nanotetrahedrons, which can easily self-aggregated and crystallized into porous and polycrystalline microspheres. The spontaneous, biobased organization of Pt NCs allow the intrinsic aggregation-induced emission (AIE) features in terms of the platinophilic interactions between Pt(II)-Hb complexes on the Pt(0) cores, thereby controlling the degree of aggregation and the luminescent intensity of Pt(0)@Pt(II)−Hb core−shell NCs. The Hb-Pt NCs exhibited high-performance electrocatalytic oxygen reduction providing a fundamental basis for outstanding catalytic enhancement of Hb-Pt catalysts based on morphology dependent and active site concentration for the four-electron reduction of oxygen. The as-prepared Hb-Pt NCs also exhibited high potential to use in cellular labeling and imaging thanks to the excellent photostability, chemical stability, and low cytotoxicity.